EverSource Wealth Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3K | Buy |
2,265
+1,195
| +112% | +$10.7K | ﹤0.01% | 2268 |
|
|
2025
Q1 | $8.03K | Buy |
1,070
+920
| +613% | +$6.9K | ﹤0.01% | 2236 |
|
|
2024
Q4 | $1.13K | Buy |
150
+50
| +50% | +$376 | ﹤0.01% | 2924 |
|
|
2024
Q3 | $760 | Hold |
100
| – | – | ﹤0.01% | 2776 |
|
|
2024
Q2 | $728 | Hold |
100
| – | – | ﹤0.01% | 2801 |
|
|
2024
Q1 | $413 | Hold |
100
| – | – | ﹤0.01% | 2756 |
|
|
2023
Q4 | $599 | Hold |
100
| – | – | ﹤0.01% | 2493 |
|
|
2023
Q3 | $708 | Hold |
100
| – | – | ﹤0.01% | 2322 |
|
|
2023
Q2 | $704 | Hold |
100
| – | – | ﹤0.01% | 2291 |
|
|
2023
Q1 | $834 | Sell |
100
-1,855
| -95% | -$15.5K | ﹤0.01% | 2150 |
|
|
2022
Q4 | $22.4K | Sell |
1,955
-1,000
| -34% | -$11.5K | ﹤0.01% | 1028 |
|
|
2022
Q3 | $38K | Hold |
2,955
| – | – | 0.01% | 706 |
|
|
2022
Q2 | $32K | Hold |
2,955
| – | – | 0.01% | 708 |
|
|
2022
Q1 | $48K | Hold |
2,955
| – | – | 0.01% | 469 |
|
|
2021
Q4 | $41K | Buy |
+2,955
| New | +$41K | 0.01% | 460 |
|